Ildong Pharmaceutical Co., Ltd. (KRX:249420)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,040
-890 (-5.26%)
Jun 26, 2026, 3:30 PM KST
Market Cap505.39B +43.8%
Revenue (ttm)572.95B -4.5%
Net Income34.91B
EPS1,137.71
Shares Out 31.51M
PE Ratio14.10
Forward PEn/a
Dividend200.00 (1.25%)
Ex-Dividend DateMar 30, 2026
Volume140,530
Open16,810
Previous Close16,930
Day's Range15,590 - 16,820
52-Week Range12,400 - 45,050
Beta0.82
Analystsn/a
Price Targetn/a
Earnings DateJul 30, 2026

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provide... [Read more]

Sector Healthcare
Founded 1941
Employees 1,061
Stock Exchange Korea Stock Exchange
Ticker Symbol 249420
Full Company Profile

Financial Performance

Financial Statements